Characteristics of binding of a low affinity, noncooperative insulin [( LeuB25]insulin) to IM-9 lymphocytes.

[Leu-B25]insulin is a low affinity insulin analog which does not increase the rate of dissociation of 125I-insulin from insulin receptors (i.e. does not display negative cooperativity). We have studied the characteristics of binding of this analog to IM-9 cultured lymphocytes, in order to determine the contribution of negative cooperativity to the curvilinear nature of Scatchard plots typical of insulin binding data. The affinity of [LeuB25]insulin for receptors was approximately 1% that of insulin, as determined by its ability to inhibit 125I-insulin binding. Monoiodinated preparations of insulin and of [LeuB25]insulin were produced, labeled in the tyrosine at position 14 of the A chain. These 125I-TyrA14-labeled species were used in all studies. Both native insulin and a serum containing antiinsulin receptor antibodies were equally potent at inhibiting binding of 125I-[LeuB25]insulin and 125I-native insulin, suggesting that they bind to the same population of receptors. Native insulin (100 ng/ml) increased the rate of dissociation of both 125I-insulin and 125I-[LeuB25]insulin. However, [LeuB25]insulin (2.5 micrograms/ml) did not increase the rates of dissociation of either 125I-insulin or 125I-[LeuB25]insulin (i.e. it did not display negative cooperativity). Competition curves and Scatchard plots were constructed using 125I-[LeuB25]insulin and unlabeled analog. Half-maximal inhibition of 125I-[LeuB25]insulin binding was seen at a [LeuB25]insulin concentration of approximately 500 ng/ml. More importantly, the Scatchard plot of these binding data was markedly curvilinear, as is typical of insulin binding data. In summary, a non-cooperative insulin analog, [LeuB25]insulin, yielded curvilinear Scatchard plots, indicating that negative cooperativity is not the full explanation of the curvilinear nature of Scatchard plots of insulin binding data. Therefore, an alternative explanation, such as the existence of heterogeneous receptor states, with differing affinities for the hormone, must contribute to the nonlinearity of these plots.

[1]  J. Olefsky,et al.  Surface binding and rates of internalization of 125I-insulin in adipocytes and IM-9 lymphocytes. , 1982, The Journal of biological chemistry.

[2]  J. Massagué,et al.  Direct modulation of insulin-like growth factor-II receptor affinity by insulin action in adipocytes and H-35 hepatoma cells , 1982 .

[3]  J. Olefsky,et al.  Relationship between negative cooperativity and insulin action. , 1981, Biochemistry.

[4]  J. Livingston,et al.  Effects of insulin on insulin-binding components extracted from rat fat cell membranes , 1979, Nature.

[5]  B. Haase,et al.  Insulin binding to the human lymphocyte receptor. Evaluation of the negative cooperativity model. , 1977, The Journal of biological chemistry.

[6]  C. Kahn,et al.  Insulin-induced dissociation of its receptor into subunits: possible molecular concomitant of negative cooperativity. , 1976, Biochemical and biophysical research communications.

[7]  J. Roth,et al.  Site-site interactions among insulin receptors. Characterization of the negative cooperativity. , 1976, The Journal of biological chemistry.

[8]  P. Cuatrecasas,et al.  Binding of insulin and other hormones to non-receptor materials: saturability, specificity and apparent "negative cooperativity". , 1975, Biochemical and biophysical research communications.

[9]  D. Neville,et al.  Insulin interactions with its receptors: experimental evidence for negative cooperativity. , 1973, Biochemical and biophysical research communications.

[10]  C. Jacquemin,et al.  Effect of iodination on the biological activity of insulin. , 1972, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .